Patients with metabolic illnesses are more likely to develop new mental disorders following the COVID-19 pandemic

After the COVID-19 pandemic, little is known about new-onset mental illnesses amongindividuals with metabolic conditions. Here, we sought to determine the parameters linked tothe emergence of new-onset mental diseases and investigate the shifts in mental health afterthe COVID-19 pandemic.Changes in mental health scores and new-onset alcohol use disorder,anxiety, and depression after the COVID-19 pandemic were evaluated. Additionally, theirrelationship to exposures relevant to sociodemographic, clinical, and self-perceived emotionalstates was investigated.The risk of developing new-onset depression (hypertension: odds ratio[OR], 1.22; 95% CI 1.01–1.47; diabetes: OR 1.8; 95% CI 1.25–2.6; obesity: OR 1.66; 95% CI1.43–1.95) and anxiety (hypertension: OR 1.32; 95% CI 1.06–1.63; diabetes: OR 1.66; 95% CI1.06–2.62; obesity: OR 1.2; 95% CI 0.99–1.44) after the COVID-19 pandemic was substantiallycorrelated with prevalent metabolic diseases. While the Alcohol Use Disorder Identification Test(AUDIT) score declined over time (beta, − 0.24; 95% CI − 0.30 to − 0.18), the Patient HealthQuestionnaire-9 (PHQ-9; beta, 0.32; 95% CI 0.29–0.35) and Generalized Anxiety Disorder-7(GAD-7; beta, 0.10; 95% CI 0.06–0.13) scores significantly increased during the COVID-19pandemic. The increased rise in PHQ-9 and GAD-7 scores after the pandemic was linked topreexisting metabolic illnesses. After the COVID-19 pandemic, adults with metabolic diseasesare more likely to experience new-onset anxiety, depression, and alcohol use problems.